PARTICIPANTS WITH MILD HEPATIC IMPAIRMENT

Clinical trials for PARTICIPANTS WITH MILD HEPATIC IMPAIRMENT explained in plain language.

Never miss a new study

Get alerted when new PARTICIPANTS WITH MILD HEPATIC IMPAIRMENT trials appear

Sign up with your email to follow new studies for PARTICIPANTS WITH MILD HEPATIC IMPAIRMENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Liver function may change how ammoxetine works

Knowledge-focused Recruiting now

This trial investigates how ammoxetine, a drug given as an enteric-coated tablet, is processed by the body in people with mild or moderate liver impairment compared to those with normal liver function. Participants take a 20 mg dose daily for six days, and researchers measure dru…

Matched conditions: PARTICIPANTS WITH MILD HEPATIC IMPAIRMENT

Phase: PHASE1 • Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. • Aim: Knowledge-focused

Last updated Jul 12, 2026 00:00 UTC

PARTICIPANTS WITH MILD HEPATIC IMPAIRMENT

Get alerted when new PARTICIPANTS WITH MILD HEPATIC IMPAIRMENT trials appear

Liver function may change how ammoxetine works